- #389 Nityananda Reddy & family ₹9,600 Cr

About Aurobindo Antibiotics Private Limited
Data last updated:
Aurobindo Antibiotics Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India, a subsidiary of Aurobindo Pharma Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 October 2020 and has been in existence for over 6 years.
Its director Nityananda Reddy and family are #389 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24110AP2020PTC115965.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Sadananda Reddy Sannareddy and Gopala Krishna Reddy Penupolu.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit 14 Jn Pharma City Plot No 17 Rno.10 11 & 19 20 E Bonangi Vlg, Visakhapatnam, Andhra Pradesh, India – 531021.
The company has about 1 employee on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company has 1 deal on record (1 rights issue); the latest was in June 2021.
For more details, the company can be reached via its website aurobindo.com.
Company details
Recognitions & Rankings of Aurobindo Antibiotics
Contact details
Aurobindo Antibiotics Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its website is aurobindo.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit 14 Jn Pharma City Plot No 17 Rno.10 11 & 19 20 E Bonangi Vlg, Visakhapatnam, Andhra Pradesh, India – 531021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aurobindo Antibiotics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aurobindo Antibiotics Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Aurobindo Antibiotics Private Limited, buy the company report.
Board of directors of Aurobindo Antibiotics Private Limited
Aurobindo Antibiotics has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sadananda Reddy Sannareddy Also directs: Panchatatva Healthcare LLP, Aurozest Private Limited | Director | 06 Oct 2020 | 6 Years 0 Months | Current |
| Gopala Krishna Reddy Penupolu | Director | 06 Oct 2020 | 6 Years 0 Months | Current |
| Bhanu Murthy Chavali | Director | 06 Oct 2020 | 6 Years 0 Months | Current |
| Nityananda Reddy Kambam Also directs: Aurobindo Pharma Ltd, Apl Healthcare Limited, Apitoria Pharma Private Limited and 5 more | Director | 26 Dec 2022 | 3 Years 10 Months | Current |
Auditor
Aurobindo Antibiotics Private Limited is audited by G P M &ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G P M &ASSOCIATES | FY 2023 | 015343S |
Shareholding
The shareholding of Aurobindo Antibiotics Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Aurobindo Antibiotics Private Limited, buy the company report.
Deals & funding
Aurobindo Antibiotics Private Limited has 1 deal on record (1 rights issue); the latest was in June 2021.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2021 | Rights issue | ₹99 Lakh | Investors: Aurobindo Pharma Ltd |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Aurobindo Antibiotics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aurobindo Antibiotics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Aurobindo Antibiotics has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Lyfius Pharma Private Limited | U24299AP2020PTC116443 | |
| Qule Pharma Private Limited | U24304AP2020PTC116442 |
To see the full group structure of Aurobindo Antibiotics Private Limited, buy the company report.
GST
No GST registration is on our record for Aurobindo Antibiotics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aurobindo Antibiotics Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Nityananda Reddy Kambam was appointed as Director on 26 Dec 2022.
News
Frequently asked questions
Aurobindo Antibiotics is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 October 2020 (6+ years old) and is registered under CIN U24110AP2020PTC115965.
Aurobindo Antibiotics has 4 current directors:
- Sadananda Reddy Sannareddy - Director
- Gopala Krishna Reddy Penupolu - Director
- Bhanu Murthy Chavali - Director
- Nityananda Reddy Kambam - Director
The latest financial statements of Aurobindo Antibiotics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Aurobindo Antibiotics is U24110AP2020PTC115965. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aurobindo Antibiotics was incorporated on 06 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Vijayawada.
Aurobindo Antibiotics has 1 deal on record (1 rights issue); the latest was in June 2021.
Nityananda Reddy Kambam was appointed as Director on 26 Dec 2022. Bhanu Murthy Chavali was appointed as Director on 06 Oct 2020. Gopala Krishna Reddy Penupolu was appointed as Director on 06 Oct 2020. Aurobindo Antibiotics has 4 board changes on record in total.
Aurobindo Antibiotics can be reached through the website aurobindo.com. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The registered office of Aurobindo Antibiotics is at Unit 14 Jn Pharma City Plot No 17 Rno.10 11 & 19 20 E Bonangi Vlg, Visakhapatnam, Andhra Pradesh, India – 531021.
Aurobindo Antibiotics operates in the pharma industry, in the drug formulation and development segment.